Last updated: June 14, 2026

Back to directory

Nuvo INVU medical AI product profile

Remote pregnancy monitoring platform that uses a wearable sensor band and cloud-based processing to support clinician-ordered antepartum fetal surveillance from home or healthcare settings.

Screenshot of the official Nuvo INVU product page
Clinical operations and revenue cycle

Best fit

Programs that need a governed way to extend maternal-fetal surveillance outside the clinic while keeping ordering, review, interpretation, and escalation under clinician-controlled protocols.

Primary use case
FDA-cleared remote maternal-fetal monitoring with wearable sensor-band acquisition, cloud processing, patient and clinician applications, fetal heart rate, maternal heart rate, and uterine activity review
Audience
OB/GYN practices, maternal-fetal medicine teams, virtual maternity programs, health systems, and perinatal monitoring programs evaluating at-home non-stress testing and fetal surveillance workflows
Risk level
High
Pricing signal
Commercial and leasing details vary by program; verify current device access, clinical service, implementation, support, privacy, and FDA-labeling terms with Nuvo.
Official sources
5 official sources

Compare within workflow: Clinical operations and revenue cycle · comparison shortlist · source index

Regulatory snapshot

StatusFDA-cleared Class II maternal-fetal monitor and home uterine activity monitor for ordered antepartum fetal surveillance workflows; verify current labeling and software version before deployment.
Review route510(k) K210025 and K221046.
Intended useNon-invasively measures and displays fetal heart rate, maternal heart rate, and uterine activity for pregnant women at 32 weeks gestation or later with singleton pregnancy, for use by healthcare professionals or patients at home on physician order.
Verification noteConfirm current FDA database records, complete indications, contraindications, warnings, precautions, device version, care protocols, and whether any AI or predictive features are covered by the cleared intended use.
Sourcewww.accessdata.fda.gov / cdrh_docs / pdf22

Regulatory, privacy, evidence, and workflow lens

Product-specific review. These product-specific signals summarize what the cited sources imply before treating Nuvo INVU as safe for a local clinical, operational, or research workflow.

Regulatory / FDATreat as FDA-cleared maternal-fetal monitoring software and hardware; match local use to the exact 510(k), gestational-age, singleton-pregnancy, prescription-use, antepartum-surveillance, home-or-facility, and non-preterm-prevention labeling.
PrivacyReview patient app, clinician app, EMR API, monitoring-session data, sensor and shipping data, support recordings or transcripts, cloud processing, retention, subprocessors, BAA or provider agreement terms, and cross-border data handling before launch.
EvidenceUse FDA summaries, labeling, vendor materials, and a local pilot to test signal quality, patient setup, clinician review burden, missed sessions, false reassurance, escalation timing, and subgroup performance before relying on remote monitoring.
WorkflowBest governed as clinician-ordered remote antepartum surveillance with explicit patient instructions, monitoring windows, review queues, escalation paths, after-hours rules, downtime plans, and conversion-to-in-person-care criteria.

Where Nuvo INVU fits

Nuvo describes INVU as an AI-powered maternal-fetal remote monitoring platform that uses wearable sensors and cloud-based processing for fetal heart rate, maternal heart rate, and uterine activity monitoring. FDA 510(k) summaries K210025 and K221046 describe INVU by Nuvo as a Class II home uterine activity monitor for pregnant women at 32 weeks gestation or later with singleton pregnancy, ordered by a physician for antepartum fetal surveillance, and state that it does not prevent preterm labor or preterm birth.

Not for: Unsupervised fetal assessment, emergency triage, use before the labeled gestational-age scope, multiple gestations where unsupported, replacing in-person obstetric care, or patient self-use without physician order and care instructions.

What to verify before using Nuvo INVU

Source links

Use these links to confirm current claims, terms, regulatory status, pricing, and deployment requirements.

Related medical AI products